Publication dates

Biopharmaceutical Industry, December 2014 Market Reports from Top Publishers

You might be interested in: Therapeutics, Medical Equipment, Corporate Finance, more »


 
1-10 of about 100 reports for Biopharmaceutical

Hua Han Bio-Pharmaceutical Holdings Ltd

Hua Han Bio-Pharmaceutical Holdings Ltd

  • $ 55
  • Company report
  • December 2014
  • by Wright Investors' Service

... Sales and 52-week price change) and financial position (long-term debt/equity). Also included for hua han bio-pharmaceutical holdings ltd are the company description, recent stock performance, profitability ...

Zhenxing Biopharmaceutical & Chemical Inc

Zhenxing Biopharmaceutical & Chemical Inc

  • $ 55
  • Company report
  • December 2014
  • by Wright Investors' Service

... Sales and 52-week price change) and financial position (long-term debt/equity). Also included for zhenxing biopharmaceutical & chemical inc are the company description, recent stock performance, profitability ...

The Russian Biopharmaceuticals and Biomedicine MarketĀ : From Import Substitution to Innovation

The Russian Biopharmaceuticals and Biomedicine MarketĀ : From Import Substitution to Innovation

  • $ 1 500
  • Industry report
  • December 2014
  • by Frost & Sullivan

... Monoclonal antibodies (mabs), cytokines, and hormones. Biocad, r-pharm, generium, and human stem cells institute are emerging as national leaders in biopharmaceuticals and biomedicine ...

RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

  • $ 55
  • Company report
  • December 2014
  • by Wright Investors' Service

... Equity). Also included for regenerx biopharmaceuticals, inc. Are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub ...

Accentia Biopharmaceuticals, Inc.

Accentia Biopharmaceuticals, Inc.

  • $ 55
  • Company report
  • December 2014
  • by Wright Investors' Service

... Accentia biopharmaceuticals, inc. A textual analysis of the financial results for accentia biopharmaceuticals, inc. Compared to selected competitors. Also included are quantitative analyses ...

XTL BIopharmaceuticals Limited

XTL BIopharmaceuticals Limited

  • $ 55
  • Company report
  • December 2014
  • by Wright Investors' Service

... Included for xtl biopharmaceuticals limited are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub-industry, fiscal ...

Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc.

  • $ 55
  • Company report
  • December 2014
  • by Wright Investors' Service

... Equity). Also included for keryx biopharmaceuticals, inc. Are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub ...

RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014

RegeneRx Biopharmaceuticals, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

... The report summarizes all the dormant and discontinued pipeline projects- latest company statement - latest news and deals relating to the regenerx biopharmaceuticals, inc.'S pipeline products ...

Taigen Biopharmaceuticals Holdings Ltd

Taigen Biopharmaceuticals Holdings Ltd

  • $ 55
  • Company report
  • December 2014
  • by Wright Investors' Service

... Taigen biopharmaceuticals holdings ltd a textual analysis of the financial results for taigen biopharmaceuticals holdings ltd compared to selected competitors. Also included are quantitative ...

China Biopharmaceuticals Mfg. Industry Data Report

China Biopharmaceuticals Mfg. Industry Data Report

  • $ 580
  • Industry report
  • December 2014
  • by Beijing Zeefer Consulting Ltd

... Figures to easily compare and contrast the regional development status in term of the biopharmaceuticals mfg. Industry based on the calculation of zeefer industry distribution index, as well as other ...

About 2 200 reports for Biopharmaceutical

Download Unlimited Documents from Trusted Public Sources

R d Analysis in the US

  • March 2013
    131 pages
  • R d  

    Biotech  

    Medicine  

  • United States  

    North America  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.